Cytometry Part B-Clinical Cytometry

Article	Citations
High‐sensitivity flow cytometric assays: Considerations for design control and analytical validation for identification of Rare events	29
Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European LeukemiaNet	23
CD319 (SLAMF7) an alternative marker for detecting plasma cells in the presence of daratumumab or elotuzumab	23
A flow cytometric assay for HLA‐DR expression on monocytes validated as a biomarker for enrollment in sepsis clinical trials	23
Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analyses	22
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS‐Flow	21
An easy and reliable whole blood freezing method for flow cytometry immuno‐phenotyping and functional analyses	19
Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometry	16
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues	16
Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by theELN iMDSflow working group	15
Automated leukocyte parameters are useful in the assessment of myelodysplastic syndromes	15
ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometry	15
Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact	15
ESCCA/ISCCA protocol for the analysis of cerebrospinal fluid by multiparametric flow‐cytometry in hematological malignancies	15
Radar plots facilitate differential diagnosis of acute promyelocytic leukemia and NPM1+ acute myeloid leukemia by flow cytometry	14
Normal or reactive minor cell populations in bone marrow and peripheral blood mimic minimal residual leukemia by flow cytometry	14
Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine‐learning assisted morphometrics	13
B‐lineage antigens that are useful to substitute CD19 for minimal residual disease monitoring in B cell precursor acute lymphoblastic leukemia after CD19 targeting	13
Chimerism evaluation in measurable residual disease‐suspected cells isolated by flow cell sorting as a reliable tool for measurable residual disease verification in acute leukemia patients after allog	12
Increased TOX expression concurrent with PD‐1, Tim‐3, and CD244 expression in T cells from patients with acute myeloid leukemia	12
Flow cytometric method transfer: Recommendations for best practice	12
Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis	12
New cytometry tools for immune monitoring during cancer immunotherapy	11
14‐Color single tube for flow cytometric characterization of CD5+ B‐LPDs and high sensitivity automated minimal residual disease quantitation of CLL/SLL	11
Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes	11

Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through ass	10
Immunophenotypic shift in the B‐cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B‐lymphoblastic leukemia	10
Leukocyte immunoglobulin‐like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation	10
Relevance of polyclonal plasma cells and post‐therapy immunomodulation in measurable residual disease assessment in multiple myeloma	9
Clinical and laboratory features associated with myeloperoxidase expression in pediatric B‐lymphoblastic leukemia	9
Peripheral innate and adaptive immune cells during COVID‐19: Functional neutrophils, pro‐inflammatory monocytes, and half‐dead lymphocytes	9
Routine flow cytometry approach for the evaluation of solid tumor neoplasms and immune cells in minimally invasive samples	9
Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy	9
Illuminating the immunopathology of SARS‐CoV‐2	9
Comprehensive immunophenotypic study of acute myeloid leukemia with KMT2A (MLL) rearrangement in adults: A single‐institution experience	8
PD‐1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome	8
Machine learning optimized multiparameter radar plots for B‐cell acute lymphoblastic leukemia minimal residual disease analysis	8
The flow cytometry myeloid progenitor count: A reproducible parameter for diagnosis and prognosis of myelodysplastic syndromes	7
Highly sensitive single tube B‐lymphoblastic leukemia/lymphoma minimal/measurable residual disease test robust to surface antigen directed therapy	7
Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors	7
Development and validation of a high‐parameter mass cytometry workflow to decipher immunomodulatory changes in celiac disease	7
Validation of inducible basophil biomarkers: Time, temperature and transportation	7
Steric hindrance: A practical (and frequently forgotten) problem in flow cytometry	7
Best practices for optimization and validation of flow cytometry‐based receptor occupancy assays	7
Characteristic CD45RA/CD45RO maturation pattern by flow cytometry associated with the CD45 C77G polymorphism	7
A comparison and review of the flow cytometric findings in classic Hodgkin lymphoma, nodular lymphocyte predominant Hodgkin lymphoma, T cell/histiocyte rich large B cell lymphoma, and primary mediasti	7
International guidelines for the flow cytometric evaluation of peripheral blood for suspected Sézary syndrome or mycosis fungoides: Assay development/optimization, validation, and ongoing quality moni	7
Correlation between a 10‐color flow cytometric measurable residual disease (MRD) analysis and molecular MRD in adult B‐acute lymphoblastic leukemia	6
Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern‐based recognition	6
A series of case studies illustrating the role of flow cytometry in the diagnostic work‐up of myelodysplastic syndromes	6
Validation of a new multiparametric protocol to assess viability, acrosome integrity and mitochondrial activity in cooled and frozen thawed boar spermatozoa	6
Detection of CAR‐T19 cells in peripheral blood and cerebrospinal fluid: An assay applicable to routine diagnostic laboratories	6
Human leukocyte antigen‐B27 typing by flow cytometry: Comparison of three CE‐IVD methods	6
Flow cytometry‐based analysis of tumor‐leukocyte ratios in peritoneal fluid from patients with advanced gastric cancer	6
Refractory neutrophils and monocytes in patients with inflammatory bowel disease after repeated bouts of prolonged exercise	6
A rare biclonal Hairy Cell Leukemia disclosed by an integrated diagnostic approach: A case report	6
Evaluation of B‐cell intracellular signaling by monitoring the PI3K‐Akt axis in patients with common variable immunodeficiency and activated phosphoinositide 3‐kinase delta syndrome	6
Sudden blast phase in pediatric chronic myeloid leukemia‐chronic phase with abnormal lymphoid blasts detected by flow cytometry at diagnosis: Can it be considered a warning sign?	5
The impact of Down syndrome‐specific non‐malignant hematopoietic regeneration in the bone marrow on the detection of leukemic measurable residual disease	5
Bicentric evaluation of stabilizing sampling tubes for assessment of monocyte HLA‐DR expression in clinical samples	5
Diagnostic performance of the ClearLLab 10C B cell tube	5
Use of flow cytometry and cytology to differentiate breast implant‐associated anaplastic large cell lymphoma from reactive seromas in Brazilian patients	5
Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays	5
Resolving 31 colors on a standard 3‐laser full spectrum flow cytometer for immune monitoring of human blood samples	5
Analysis of human chromosomes by imaging flow cytometry	5
Unsupervised cluster analysis and subset characterization of abnormal erythropoiesis using the bioinformatic Flow‐Self Organizing Maps algorithm	5
Erroneous expression of NKG2D on granulocytes detected by phycoerythrin‐conjugated clone 149810 antibody	5
Validation of a 12‐color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection	5
Immunophenotypic characteristics of ZNF384 rearrangement compared with BCR‐ABL1, KMT2A rearrangement, and other adult B‐cell precursor	5
Letter to the editor with regard to the article entitled “Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping”	4
Malignant plasmacytes in bone marrow detected by flow cytometry as a predictor for the risk stratification system of multiple myeloma	4
Combined use of different antibody clones improves the efficiency of human leukocyte antigen B27 detection by flow cytometry	4
Circulating CD22+/CD19−/CD24− progenitors and CD22+/CD19+/CD24− mature B cells: Diagnostic pitfalls for minimal residual disease detec	4
Mature B‐ and plasma‐cell flow cytometric analysis: A review of the impact of targeted therapy	4
CD69flow cytometry to complement interferon‐γrelease assay for active tuberculosis	4

Diagnostic utility of flow cytometry based coated‐platelets assay as a biomarker to predict thrombotic or hemorrhagic phenotype in acute stroke	4
Time point‐dependent concordance and prognostic significance of flow cytometry and real time quantitative PCR for measurable/minimal residual disease detection in acute myeloid leukemia wit	4
Flow cytometry to detect bone marrow involvement by follicular lymphoma	4
CLL/SLL specifically binding to the APC fluorochrome: A previously undescribed phenomenon	4
Characterization of myelodysplastic syndromes hematopoietic stem and progenitor cells using mass cytometry	3
Expression levels and patterns of B‐cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent	3
Genomic profile of TdTpositiveMYC/BCL2 rearranged high‐grade B‐cell lymphoma supporting its diagnosis as mature aggressive lymphoma	3
CD4+ T‐cell large granular lymphocytic leukemia with STAT3 mutation and neutropenia	3
Reactive oxygen species levels differentiate CD34+ human progenitors based on CD38 expression	3
Prognostic significance of hematogone presence after autologous stem cell transplantation in patients with multiple myeloma	3
Flow cytometric analysis of CD34+CD38− cells; cell frequency and immunophenotype based on CD45RA expression pattern	3
Cross‐sectional reassessment after 4 years of clinical routine use of AQUIOS CL for absolute T cell quantitation in a university hospital	3
Optimization of monocyte gating to quantify monocyte subsets for the diagnosis of chronic myelomonocytic leukemia	3
Abnormal B‐lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia	3
Flow cytometry detection of CD138 expression continuum between monotypic B and plasma cells is associated with both high IgM peak levels and MYD88 mutation and contrib	3
Quick identification of target antigens by tissue flow cytometry for CAR‐T therapy in B‐cell malignancies	3
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry	3
Adaptation of a multiple myeloma minimal residual disease multicolor flow cytometry assay for real‐world practice	3
Spurious CD34 expression in B‐cell lymphoma due to nonspecific binding to PerCP‐Cy5.5 fluorochrome conjugates: A rare phenomenon and a diagnostic pitfall	3
Increased IFN‐γ+ and TNF‐α+ mucosal‐associated invariant T cells in patients with aplastic anemia	2
Dysplasia andPNH‐type cells in bone marrow aspirates of myelodysplastic syndromes	2
Recommendations for using artificial intelligence in clinical flow cytometry	2
The patterns and diagnostic significance of the lack of surface immunoglobulin light chain on mature B cells in clinical samples for lymphoma workup	2
Comparison of flowcytometry‐based scoring system for the diagnosis of early T precursor‐acute lymphoblastic leukemia	2
Dysplastic agranular basophils identified by flow cytometry	2
Deciphering stage 0 hematogones by flow cytometry in follow‐up bone marrow samples of pediatric B—Acute lymphoblastic leukemia cases: A potential mimicker of residual disease after anti CD19 therapy	2
An unusual case of cytoplasmic CD3 expressing BPDCN supporting the T‐lineage origin of plasmacytoid dendritic cells	2
Characteristic flow cytometric profile of ectopic intra‐thyroidal thymic tissue in children	2
Biclonality in hairy cell leukemia: Co‐occurrence of CD10+ and CD10− clones with different surface membrane immunoglobulin expression	2
Biclonal cluster lymphoma: SLL/CLL and FL diagnosed on fine needle aspirate flow cytometry—Report of an interesting case	2
CD200 expression on Sezary cells: A valuable tool for flow cytometric assessment of peripheral blood T‐cell neoplasms	2
CD5‐negative chronic lymphocytic leukemia: Does this entity really exist?	2
Identification of a specific immunophenotype associated with a consistent pattern of genetic mutations including SRFS2 and gene expression profile in MDS	2
Patients without cutaneous T‐cell lymphoma frequently harbor CD4 T‐lymphocytes that lack CD26 and/or CD7	2
Biomarkers for the clinical development of antiviral therapies	2
Automation in flow cytometry: Guidelines and review of systems	2
Erythroid side scatter: A parameter that improves diagnostic accuracy of flow cytometry myelodysplastic syndrome scoring	2
Partial recapitulation of fetal thymic T‐cell constitution postnatally in a patient with cartilage hair hypoplasia‐anauxetic dysplasia spectrum disorder: A case report	2
Addition of formaldehyde releaser imidazolidinyl urea and MOPS buffer to urine samples enables delayed processing for flow cytometric analysis of urinary cells: A simple, two step conservat	2
Acute leukemia of ambiguous lineage, not otherwise specified with FLT3‐ITD mutation and a possible origin in the common lymphoid progenitor	2
Dissecting the sCD3‐CD4+ T‐cell population: A valuable screening tool for angioimmunoblastic T‐cell lymphoma	2
Applicability of the long‐term uncertainty in measurement (LTUM) method for analytical performance assessment in clinical cytometry laboratories	2
Integration of T‐cell clonality screening using TRBC‐1 in lymphoma suspect samples by flow cytometry	2
Automated quantification of measurable residual disease in chronic lymphocytic leukemia using an artificial intelligence‐assisted workflow	2
Reactive NK cell lymphocytosis with atypical immunophenotype in a chronic HIV‐infected patient	2
IgE‐mediated bleomycin hypersensitivity: Evidence from drug‐reactive T lymphocytes	2
Standardization of flow cytometric detection of antigen expression	2
Use of a hybrid intelligence decision tree to identify mature B‐cell neoplasms	2
Monitoring of tumor cells by flow cytometry permits rapid evaluation of disease progression in monomorphic epitheliotropic intestinal T‐cell lymphoma	2
Imaging flow cytometry reveals a subset of TdT negative T‐ALL blasts with very low forward scatter on conventional flow cytometry	2
Alignment, segmentation and neighborhood analysis in cyclic immunohistochemistry data using CASSATT	2
Detecting hypodiploidy with endoreduplication and masked hypodiploidy in B‐cell acute lymphoblastic leukemia using multicolor flow cytometry	2
Issue Highlights	1
Urinary red blood cell‐derived microparticles and phosphatidylserine‐exposing red blood cells in glomerular and non‐glomerular hematuria patients	1
Extranodal NK/T‐cell lymphoma with isolated central nervous system relapse: A defiant disease and the role of flow cytometry in monitoring	1
Phenotype and oxidative burst of low‐density neutrophil subpopulations are altered in common variable immunodeficiency patients	1
Maturational dyssynchrony in benign B‐cell precursors following lymphocyte depleting chemotherapy: A potential pitfall for B‐lymphoblastic leukemia minimal/measurable residual di	1
Technical, gating and interpretation recommendations for the partitioning of circulating monocyte subsets assessed by flow cytometry	1
CD34 and CD117 negative pure erythroid leukemia and phenotypic differences with acute megakaryoblastic leukemia	1
External quality assessment of flow cytometric bronchoalveolar lavage cellular analysis: 20 years' experience in The Netherlands	1
Contribution of anti‐T cell receptor beta constant 1 to the classification of a mediastinal mass	1
The role of CD20+ T cells: Insights in human peripheral blood	1
Optimization of a flow cytometry test for routine monitoring of B cell maturation antigen targeted CAR in peripheral blood	1
The use of erythrocytes as biomarkers with a timeline	1
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry	1
Whole blood no‐lyse no‐wash micromethod for the quantitative measurement of monocyte HLA‐DR	1
Where diagnosis for myelodysplastic neoplasms (MDS) stands today and where it will go: The role of flow cytometry in evaluation of MDS	1
ROR1 expression in mature B lymphoid neoplasms by flow cytometry	1
Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies	1
Monocyte HLA‐DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds	1
An alternative processing approach to increase CD138 intensity in flow cytometric analysis of plasma cells	1
TRBC1 in flow cytometry: Assay development, validation, and reporting considerations	1
Bone marrow follicular‐like T cells in monoclonal gammopathies	1
MAGIC‐DR: An interpretable machine‐learning guided approach for acute myeloid leukemia measurable residual disease analysis	1
Eight‐year follow up of a case of persistent polyclonal B cell lymphocytosis: Immunophenotypic findings pre‐ and postsplenectomy	1
Acquired RUNX1::CBFA2T2 fusion at extramedullary relapse in a patient of PDGFRA rearranged acute myeloid leukemia post allogenic HSCT	1
Minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukemia by semi‐automated identification of normal hematopoietic cells: A EuroFlow study	1
CD19 negative diffuse large B‐cell lymphoma presenting in leukemic phase	1
CD19‐negative B‐cell precursors in bone marrow: A potential mimicker for CD19‐negative B‐lymphoblastic leukemia by flow cytometry in patients with anti‐CD19 treatment	1
Log reduction of leukemic cells and minimal residual disease by flow cytometry represent effective predictors of clinical outcome in elderly patients with acute myeloid leukemia	1

An ultra‐rapid screening method for acute leukemias	1
Correlation of morphological and flow cytometric findings in the diagnosis of transient red cell aplasia due to parvovirus B19 infection	1
Immunophenotypic portrait of leukemia‐associated‐phenotype markers in B acute lymphoblastic leukemia	1
Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience	1
Role of flow cytometric immunophenotyping in the diagnosis of breast implant‐associated anaplastic large cell lymphoma: A 6‐year, single‐institution experience	1
BCR::ABL1 fusion gene positive de novo acute myeloid leukemia with coexistence of NRAS mutation and presented with a peculiar CD58 positive immunophenotype	1
Evaluation of Versalyse as an alternative red blood cell lysing agent in the evaluation of CD34 stem and progenitor cells with the ISHAGE guidelines	1
Authors reply to the letter to editor with regard to the article titled “Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping”	1
Transient abnormal lymphomyelopoiesis in a newborn with PTPN11 mutation associated Noonan syndrome	1
Analysis of cerebrospinal fluid for the diagnosis of CNS lymphoma: Comparison of the ESCCA/ISCCA protocol and real‐world data of the CytHem/LOC F	1
Dual peaks on flow cytometric DNA ploidy analysis in chronic lymphocytic leukemia with Richter transformation	1
Clinical, immunophenotypic, and cytogenetic characteristics of high‐grade myelodysplastic syndromes with CD41‐positive progenitor cells	1
Prediction of standard cell types and functional markers from textual descriptions of flow cytometry gating definitions using machine learning	1
Comparison of a modified flow cytometry osmotic fragility test with the classical method for the diagnosis of hereditary spherocytosis	1